HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alireza Nakhaee Selected Research

Proteins (Proteins, Gene)

5/2005Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alireza Nakhaee Research Topics

Disease

3Body Weight (Weight, Body)
02/2015 - 01/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2022 - 01/2022
2Cardiovascular Diseases (Cardiovascular Disease)
07/2021 - 05/2015
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 06/2015
2Coronary Artery Disease (Coronary Atherosclerosis)
06/2012 - 01/2010
2Hyperglycemia
08/2010 - 10/2009
2Diabetes Mellitus
01/2010 - 10/2009
2Infections
01/2010 - 05/2005
2Visceral Leishmaniasis (Kala Azar)
05/2005 - 03/2003
1Carcinogenesis
12/2022
1Neoplasms (Cancer)
01/2022
1Hypersensitivity (Allergy)
01/2020
1Aphthous Stomatitis (Aphthous Ulcer)
01/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2019
1Spontaneous Abortion (Miscarriage)
06/2017
1Chronic Renal Insufficiency
02/2017
1Xerostomia
02/2017
1Oral Manifestations
02/2017
1Hemorrhage
02/2017
1Halitosis
02/2017
1Calculi (Calculus)
02/2017
1Urinary Tract Infections (Urinary Tract Infection)
03/2016
1Hyperthyroidism
01/2016
1Hypothyroidism
01/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2015
1Communicable Diseases (Infectious Diseases)
05/2015
1Type 2 Diabetes Mellitus (MODY)
05/2015
1Pathologic Processes
06/2012
1Diabetes Complications
08/2010
1Pulmonary Tuberculosis
02/2010

Drug/Important Bio-Agent (IBA)

3AntioxidantsIBA
03/2016 - 10/2009
3Drinking WaterIBA
01/2016 - 01/2010
2Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2015 - 10/2009
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2012 - 01/2010
2Streptozocin (Streptozotocin)FDA Link
01/2010 - 10/2009
2Cysteine Proteases (Cysteine Protease)IBA
05/2005 - 03/2003
1Caspase 9IBA
12/2022
1Caspase 8 (Caspase-8)IBA
12/2022
1Antisense RNA (Anti-Sense RNA)IBA
01/2022
1Long Noncoding RNAIBA
01/2022
1ChemokinesIBA
07/2021
1CytokinesIBA
07/2021
1Immunoglobulin E (IgE)IBA
01/2020
1Eosinophil Cationic ProteinIBA
01/2020
1SirtuinsIBA
07/2019
1Sirtuin 1IBA
07/2019
1HLA-G Antigens (HLA G)IBA
06/2017
1Urea (Carbamide)FDA LinkGeneric
02/2017
1CalciumIBA
02/2017
1Oxidants (Oxidizing Agents)IBA
03/2016
1PropylthiouracilFDA Link
01/2016
1SaltsIBA
01/2016
1SodiumIBA
01/2016
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2016
1HaptoglobinsIBA
05/2015
1Arginine (L-Arginine)FDA Link
06/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2012
1Nitric Oxide Synthase (NO Synthase)IBA
06/2012
1sodium tungstate(VI) (sodium tungstate)IBA
08/2010
1Free RadicalsIBA
08/2010
1GoldIBA
02/2010
1Recombinant DNA (Recombinant DNA Research)IBA
05/2005
1VaccinesIBA
05/2005
1CPG-oligonucleotideIBA
05/2005
1Proteins (Proteins, Gene)FDA Link
05/2005
1Monatide (IMS 3015)IBA
05/2005
1DNA (Deoxyribonucleic Acid)IBA
05/2005

Therapy/Procedure

2Intraperitoneal Injections
02/2015 - 01/2010
2Traditional Medicine (Folk Remedies)
01/2010 - 10/2009
1Renal Dialysis (Hemodialysis)
02/2017